Certified by Founder Lodge
TrialSpark
United States - New York, NY
INVESTOR
1 Disclosed Funding Rounds $10,000,000
1 Participating Investments
-
Founded date
2013
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
TrialSpark is a technology company that helps bring treatments to patients faster.
Today, clinical trials are the bottleneck to bringing life-saving treatments to patients. Trials are slow
January
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
